Bluejay Diagnostics Q1 EPS $(1.95) Up From $(13.48) YoY

Benzinga Newsdesk www.benzinga.com Positive 56.2%

Neg 0% Neu 0% Pos 56.2%

Bluejay Diagnostics (NASDAQ:BJDX) reported quarterly losses of $(1.95) per share. This is a 85.53 percent increase over losses of $(13.48) per share from the same period last year.